# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 676 results.
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Status: Not yet recruiting
Last Changed: Nov 08, 2019
First Received: Nov 07, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASTX660, ASTX727
NK Cell Infusion for Patients With Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Jan 09, 2020
First Received: Jan 09, 2020
Disease(s): Acute Myeloid Leukemia
Intervention(s): chemotherapy combined with NK cells infusion
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Feb 06, 2020
First Received: Nov 30, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Minnelide
Locations: H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Nov 02, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Sample Collection Blood, Stool Sample
Locations: Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Long-term Outcomes for Acute Myeloid Leukemia Patients
Status: Not yet recruiting
Last Changed: Jan 28, 2019
First Received: Nov 28, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Questionnaire
Locations: UZ Gasthuisberg, Leuven, Belgium
CHR Citadelle-CHU, Liège, Belgium
University of Liège, Liège, Belgium
KBC Rijeka, Rijeka, Croatia
University Hospital Centre Zagreb, Zagreb, Croatia
... and 40 other locations.
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Dec 08, 2014
Disease(s): Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia
Intervention(s): gilteritinib, Idarubicin, Cytarabine
Locations: Site JP00003, Nagoya, Aichi, Japan
Site JP81003, Nagoya, Aichi, Japan
Site JP81010, Narita, Chiba, Japan
Site JP81007, Yoshida-gun, Fukui, Japan
Site JP00002, Maebashi, Gunma, Japan
... and 17 other locations.
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Mar 01, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASLAN003
Locations: 1 Site, Louisville, Kentucky, United States
1 Site, Albury, New South Wales, Australia
3 Sites, Darlinghurst, New South Wales, Australia
1 Site, Waratah, New South Wales, Australia
1 Site, Douglas, Queensland, Australia
... and 4 other locations.
Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Feb 11, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Gilteritinib, Midostaurin, Daunorubicin, Cytarabine
Locations: HonorHealth Research Institute, Scottsdale, Arizona, United States
UCLA, Los Angeles, California, United States
UC Irvine Health, Orange, California, United States
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Johns Hopkins University, Baltimore, Maryland, United States
... and 12 other locations.
Investigating Integrative Therapies for Symptom Management in Adults With Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Jan 23, 2020
First Received: Dec 04, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Integrative Therapy
Locations: University of Florida, Gainesville, Florida, United States
Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Status: Recruiting
Last Changed: Sep 24, 2019
First Received: Jun 23, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): OPB-111077
Locations: Hospital 12 Octubre, Madrid, Spain
Hospital Universitario Madrid Sanchinarro, Madrid, Spain
Hospital Universitario La Fe, Valencia, Spain